Nemaura Medical Inc. Announces $8 million Senior Debt Facility Provided by Existing Investors
August 01, 2019 08:30 ET
|
Nemaura Medical Inc
Loughborough, England, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive,...
Nemaura Medical Inc. Appoints Chris Avery as Vice President of Global Business Operations to Support Global Commercial Launch of SugarBEAT®
July 18, 2019 09:00 ET
|
Nemaura Medical Inc
Loughborough, England , July 18, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable...
Nemaura Medical Inc. Submits De Novo 510(k) Application for SugarBEAT® to the U.S. Food and Drug Administration
July 10, 2019 09:00 ET
|
Nemaura Medical Inc
Loughborough, England , July 10, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable...
Nemaura Provides Fiscal 2019 Year-End Business Update
June 17, 2019 09:00 ET
|
Nemaura Medical Inc
On track to submit FDA application for SugarBEAT in mid 2019 Loughborough, England , June 17, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company...
Nemaura Medical Interview to Air on Bloomberg International on the RedChip Money Report
June 14, 2019 09:00 ET
|
Nemaura Medical Inc
Loughborough, England, June 14, 2019 (GLOBE NEWSWIRE) -- – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable...
Nemaura Announces CE Mark Approval of SugarBEAT®
May 29, 2019 09:00 ET
|
Nemaura Medical Inc
Loughborough,England, May 29, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and...
Nemaura Announces Open-Source Software for its Continuous Glucose Monitor SugarBEAT®
May 02, 2019 09:00 ET
|
Nemaura Medical Inc
Loughborough, England , May 02, 2019 (GLOBE NEWSWIRE) -- – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable...
Nemaura Announces Successful Completion of Summative Human Factors Usability Study for SugarBEAT®
April 23, 2019 08:00 ET
|
Nemaura Medical Inc
Loughborough, England , April 23, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable...
Nemaura Announces Addition of New Predictive Alert Functionality to SugarBEAT®
April 16, 2019 09:15 ET
|
Nemaura Medical Inc
Loughborough, England , April 16, 2019 (GLOBE NEWSWIRE) -- April 16, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a...
Nemaura CEO Provides Update to Shareholders
March 28, 2019 08:30 ET
|
Nemaura Medical Inc
Loughborough, England, March 28, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – March 28, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of...